Txr1: an important factor in oxaliplatin resistance in gastric cancer. [electronic resource]
Producer: 20140814Description: 807 p. digitalISSN:- 1559-131X
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Basic Helix-Loop-Helix Leucine Zipper Transcription Factors -- genetics
- Blotting, Western
- Cell Cycle -- drug effects
- Cell Proliferation -- drug effects
- Drug Resistance, Neoplasm
- Female
- Follow-Up Studies
- Humans
- Immunoenzyme Techniques
- Inhibitor of Apoptosis Proteins -- genetics
- Lymphatic Metastasis
- Male
- Middle Aged
- Neoplasm Staging
- Organoplatinum Compounds -- therapeutic use
- Oxaliplatin
- Prognosis
- RNA, Messenger -- genetics
- RNA, Small Interfering -- genetics
- Real-Time Polymerase Chain Reaction
- Repressor Proteins -- antagonists & inhibitors
- Retrospective Studies
- Reverse Transcriptase Polymerase Chain Reaction
- Stomach Neoplasms -- drug therapy
- Survival Rate
- Survivin
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.